Human Subjects Office releases new FDA Site Inspection Guidance

The Food and Drug Administration (FDA) conducts site inspections of clinical investigators involved in FDA-regulated clinical trials to determine compliance with applicable regulations.  The Human Subjects Office (HSO) Compliance Staff has released the newly created FDA Site Inspection Guidance to provide practical advice for Principal Investigators (PI) and research staff undergoing a FDA inspection.